100 Participants Needed

Telehealth Aerobic Exercise & Cognitive Training for Schizophrenia

RZ
JV
KH
Overseen ByKeith H. Nuechterlein, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of this treatment for schizophrenia?

Research shows that combining aerobic exercise with cognitive training can improve thinking skills and daily functioning in people with schizophrenia. Aerobic exercise may enhance brain function by increasing a protein that helps with learning, and when paired with cognitive training, it can lead to better cognitive flexibility and processing speed.12345

Is the combination of aerobic exercise and cognitive training safe for people with schizophrenia?

Research suggests that combining aerobic exercise with cognitive training is generally safe for people with schizophrenia. It can improve physical fitness, cognitive function, and overall well-being without significant safety concerns.678910

How does the Telehealth Aerobic Exercise & Cognitive Training treatment for schizophrenia differ from other treatments?

This treatment is unique because it combines aerobic exercise with cognitive training, which together enhance brain function and cognitive abilities more effectively than cognitive training alone. Aerobic exercise increases brain-derived neurotrophic factor (BDNF), promoting brain plasticity and improving learning capacity, which is further enhanced by cognitive training.134810

What is the purpose of this trial?

The participants in the study will receive psychiatric treatment at the UCLA Aftercare Research Program. All participants in this 12-month RCT will receive cognitive training. Half of the patients will also be randomly assigned to the aerobic exercise and strength training condition, and the other half will be randomly assigned to the Healthy Living Group condition. The primary outcome measures are improvement in cognition and level of engagement in the in-group and at-home exercise sessions. Increases in the level of the patient's serum brain-derived neurotropic factor (specifically Mature BDNF) which causes greater brain neuroplasticity and is indicator of engagement in aerobic exercise, will be measured early in the treatment phase in order to confirm engagement of this target. In order to demonstrate the feasibility and portability of this intervention outside of academic research programs, the interventions will be provided via videoconferencing. The proposed study will incorporate additional methods to maximize participation in the exercise condition, including the use of the Moderated Online Social Therapy (MOST) platform to enhance motivation for treatment based on Self-Determination Theory principles, and a "bridging" group to help the participants generalize gains to everyday functioning. In addition, the exercise group participants will receive personally tailored text reminders to exercise.

Research Team

KH

Keith H Nuechterlein, PhD

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

This trial is for individuals aged 18-45 who have experienced their first psychotic episode within the last two years and are diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder. Participants should be fluent in English, live near UCLA's Aftercare Research Program, and be able to commute there.

Inclusion Criteria

I have been diagnosed with schizophrenia, schizoaffective, or schizophreniform disorder.
I am fluent in English and understand the culture well.
First episode of a psychotic illness that began within the past two years
See 1 more

Exclusion Criteria

Premorbid IQ less than 70
Evidence of moderate or severe substance use disorder within the six months prior to the first episode or evidence of a substance-induced psychosis
I have a known neurological disorder or have had a significant head injury.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive cognitive training and are randomly assigned to either the aerobic exercise and strength training condition or the Healthy Living Group condition. The interventions are delivered via videoconferencing.

12 months
Weekly sessions via videoconferencing

Follow-up

Participants are monitored for changes in cognitive performance and engagement in exercise sessions.

3 months

Extension

Participants continue with reduced frequency of group sessions to maintain exercise and cognitive training benefits.

6 months

Treatment Details

Interventions

  • Aerobic Exercise Program
  • Chorus Participatory Text Messaging Program
  • Cognitive training
  • Healthy Living Group (HLG)
  • Moderated Online Social Therapy (MOST)
Trial Overview The study tests if cognitive training combined with either aerobic exercise or a Healthy Living Group improves cognition in patients after a first schizophrenia episode. It measures engagement levels and brain changes indicating neuroplasticity through serum BDNF levels. The program is delivered via videoconferencing to test its wider applicability.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Randomization to Combined Cognitive Training and Exercise (CT&E)Experimental Treatment4 Interventions
The primary interventions for this arm of the protocol are Cognitive Training and Exercise sessions. The Cognitive Training will be conducted in a group format using Zoom videoconferencing, with participants logging into their individual Posit Science cognitive training accounts. The Aerobic Exercise Program will consist of a physical exercise intervention of 150 minutes/week of moderate aerobic activity, over 4 days, including two group sessions (45 min duration) and two individual sessions (30 min duration in the heart rate zone), for 6 months. After the first 6 months, the group sessions will be once a week with the continuing goal of 150 minutes/week of moderate exercise.
Group II: Cognitive Training and Healthy Living Group (CT&HLG)Active Control3 Interventions
The primary interventions for this arm of the protocol are Cognitive Training and the Healthy Living Group. The Cognitive Training will be conducted in a group format using Zoom videoconferencing, with participants logging into their individual Posit Science cognitive training accounts. The participants in this arm will also participate in a Healthy Living Group, which is a didactic, educational and interactive group that is designed to offer very useful information and discussion of topics that are relevant to a healthy lifestyle. It includes manualized modules devoted to wellness, nutrition, insight, recovery, independent living, social skills, and hobbies. It meets 2 times/week for 6 months and then once a week for the next 6 months.

Aerobic Exercise Program is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Aerobic Exercise for:
  • Improvement in cognitive functioning in schizophrenia
  • Reduction in psychiatric symptoms of schizophrenia
  • Enhancement of global functioning and quality of life
🇺🇸
Approved in United States as Aerobic Exercise for:
  • Improvement in cognitive functioning in schizophrenia
  • Reduction in psychiatric symptoms of schizophrenia
  • Enhancement of global functioning and quality of life

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

A 6-month program combining cognitive training and aerobic exercise (CT&E) significantly improved cognitive function in 47 first-episode schizophrenia patients compared to cognitive training alone, especially in the first 3 months.
The study found that the amount of aerobic exercise completed was strongly linked to improvements in both cognitive abilities and work/school functioning, suggesting that exercise enhances the effectiveness of cognitive training.
Aerobic exercise enhances cognitive training effects in first-episode schizophrenia: randomized clinical trial demonstrates cognitive and functional gains.Nuechterlein, KH., McEwen, SC., Ventura, J., et al.[2023]
A 12-week aerobic exercise program significantly improved cardiorespiratory fitness in 54 veterans with schizophrenia, demonstrating its efficacy in enhancing physical health (p<.0001).
The aerobic exercise also showed trend-level improvements in social functioning, suggesting a potential link between increased fitness and better social outcomes, with a correlation of r=.42 (p<.01).
Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia.Kern, RS., Reddy, LF., Cohen, AN., et al.[2020]
Aerobic exercise (AE) significantly improved global cognition in patients with schizophrenia after 6 months, based on a review of 23 studies with 1014 participants.
Specifically, AE enhanced verbal learning, memory, reasoning, and problem-solving skills, while effects on other cognitive domains like attention and social cognition were not significant.
Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis.Xu, Y., Cai, Z., Fang, C., et al.[2022]

References

Aerobic exercise enhances cognitive training effects in first-episode schizophrenia: randomized clinical trial demonstrates cognitive and functional gains. [2023]
Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia. [2020]
Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis. [2022]
CCRT and aerobic exercise: a randomised controlled study of processing speed, cognitive flexibility, and serum BDNF expression in schizophrenia. [2022]
Aerobic exercise and cognitive functioning in schizophrenia: A pilot randomized controlled trial. [2020]
Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. [2018]
Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality. [2020]
Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study. [2020]
Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial. [2021]
Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security